Morris, Luc

Publications

Sort by

Co-Author Network

selected publications

A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer. Nature communications. 2025 Academic Article GET IT
Times cited: 9
The Role of Circulating Tumor DNA (ctDNA) in the Treatment of Human Papilloma Virus-positive (HPV+) Oropharyngeal Squamous Cell Carcinoma. Cancer journal (Sudbury, Mass.). 2025 Information Resource GET IT
Times cited: 3
Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination. Nature genetics. 2025 Academic Article GET IT
Times cited: 4
Expanding the histologic spectrum of thyroid neoplasms with NTRK1/2/3 or ALK translocation: a single-center retrospective study of 82 cases. Virchows Archiv : an international journal of pathology. 2025 Academic Article GET IT
Times cited: 1
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression. The Journal of experimental medicine. 2025 Academic Article GET IT
Times cited: 7
Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia (New York, N.Y.). 2025 Academic Article GET IT
Times cited: 4
Clinical and Pathologic Characteristics of Cytologically Indeterminate Thyroid Nodules with Non-V600E BRAF Alterations. Cancers. 2025 Academic Article GET IT
Times cited: 2
Optimizing Prognostic Assessment in High-Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System. Cancer medicine. 2025 Academic Article GET IT
Times cited: 2
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data. Nature medicine. 2025 Academic Article GET IT
Times cited: 92
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Academic Article GET IT
Times cited: 5
Outcomes of Conversion Surgery for Patients With Low-Risk Papillary Thyroid Carcinoma. JAMA otolaryngology-- head & neck surgery. 2024 Academic Article GET IT
Times cited: 8
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma. Science advances. 2024 Academic Article GET IT
Times cited: 4
Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2024 Academic Article GET IT
Times cited: 15
Active Surveillance for Pleomorphic Adenomas of the Parotid-Tumor Growth Rate, Potential Malignancy, and Surgical Sequalae. Journal of surgical oncology. 2024 Academic Article GET IT
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma. JCI insight. 2024 Academic Article GET IT
Times cited: 13
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort. Molecular diagnosis & therapy. 2024 Academic Article GET IT
Times cited: 2
Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024 Academic Article GET IT
Times cited: 8
Impact of Surveillance Imaging in Patients With HPV-Associated Oropharyngeal Carcinoma Treated With Definitive Radiation and Chemotherapy. American journal of clinical oncology. 2024 Academic Article GET IT
Times cited: 2
Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer. JAMA oncology. 2024 Academic Article GET IT
Times cited: 11
Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines. Journal of medical screening. 2024 Academic Article GET IT
Times cited: 1
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer. 2024 Academic Article GET IT
Times cited: 97
RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance. Thyroid : official journal of the American Thyroid Association. 2024 Academic Article GET IT
Times cited: 11
MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature. Oral oncology. 2024 Academic Article GET IT
Times cited: 10
A Case Series of Patients With Complex Airway Disease and Large Thyroid Tumors Anterior to the Trachea Precluding Tracheostomy. Critical care explorations. 2024 Article GET IT
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation. Oncotarget. 2024 Academic Article GET IT
Times cited: 7
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Academic Article GET IT
Times cited: 81
Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. Cancers. 2023 Academic Article GET IT
Times cited: 2
Risk of Carcinoma in Pleomorphic Adenomas of the Parotid. JAMA otolaryngology-- head & neck surgery. 2023 Academic Article GET IT
Times cited: 12
Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma. The Journal of clinical investigation. 2023 Academic Article GET IT
Times cited: 24
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer. Science immunology. 2023 Academic Article GET IT
Times cited: 87
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer. Molecular oncology. 2023 Academic Article GET IT
Times cited: 31
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. Nature medicine. 2023 Academic Article GET IT
Times cited: 47
Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities. Cancer research communications. 2023 Academic Article GET IT
Times cited: 3
Diagnostic Scrutiny and Patterns of Elevated Cancer Risk: Uncovering Overdiagnosis Through Standardized Incidence Ratios. Cureus. 2023 Information Resource GET IT
Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment. Oncoimmunology. 2023 Academic Article GET IT
Patterns of immune equilibrium and escape in indolent and progressing tumors. Cancer cell. 2023 Article GET IT
Times cited: 5
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients. Frontiers in immunology. 2023 Academic Article GET IT
Times cited: 11
Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer. The Laryngoscope. 2023 Academic Article GET IT
Times cited: 8
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Academic Article GET IT
Times cited: 28
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy. Translational cancer research. 2023 Editorial Article GET IT
Times cited: 4
FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling. Scientific reports. 2023 Academic Article GET IT
Times cited: 9
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape. Genome medicine. 2022 Academic Article GET IT
Times cited: 40
American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma. JAMA otolaryngology-- head & neck surgery. 2022 Academic Article GET IT
Times cited: 54
Relative Survival With Early-Stage Breast Cancer in Screened and Unscreened Populations. Mayo Clinic proceedings. 2022 Academic Article GET IT
Times cited: 13
Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns. Thyroid : official journal of the American Thyroid Association. 2022 Academic Article GET IT
Times cited: 53
Surgical management of T1/T2 node-negative papillary thyroid cancer with tall cell histology: Is lobectomy enough?. Surgery. 2022 Academic Article GET IT
Times cited: 10
Clonal hematopoiesis and differential outcomes after immune checkpoint blockade. Cancer cell. 2022 Article GET IT
Times cited: 21
Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy. JAMA oncology. 2022 Academic Article GET IT
Times cited: 24
Leveraging big data of immune checkpoint blockade response identifies novel potential targets. Annals of oncology : official journal of the European Society for Medical Oncology. 2022 Information Resource GET IT
Times cited: 59
Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients. The International journal of biological markers. 2022 Academic Article GET IT
Times cited: 5
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Academic Article GET IT
Times cited: 33
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity. Nature genetics. 2022 Academic Article GET IT
Times cited: 61
Cervical Pneumatocele Following Total Thyroidectomy Presenting as an Air Thyrogram. JAMA otolaryngology-- head & neck surgery. 2022 Academic Article GET IT
Transorbital embolization of cavernous sinus dural arterio-venous malformations with surgical exposure and catheterization of the superior ophthalmic vein. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2022 Article GET IT
Times cited: 4
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma. Science advances. 2022 Academic Article GET IT
Times cited: 16
Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types. Cancer research. 2022 Academic Article GET IT
Times cited: 40
Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers. 2022 Academic Article GET IT
Times cited: 14
Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma. Cancers. 2022 Academic Article GET IT
Times cited: 19
Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade. NPJ precision oncology. 2022 Academic Article GET IT
Times cited: 38
Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trial. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2022 Academic Article GET IT
Times cited: 2
Nodal Metastases in Pediatric and Adult Acinic Cell Carcinoma of the Major Salivary Glands. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2022 Academic Article GET IT
Times cited: 4
Young non-smokers with oral cancer: What are we missing and why?. Oral oncology. 2022 Academic Article GET IT
Times cited: 27
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. Journal for immunotherapy of cancer. 2022 Academic Article GET IT
Times cited: 37
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 2022 Academic Article GET IT
Times cited: 476
Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade. JAMA network open. 2022 Article GET IT
Times cited: 58
Positron Emission Tomography-Computed Tomography Imaging, Genomic Profile, and Survival in Patients With Head and Neck Cancer Receiving Immunotherapy. JAMA otolaryngology-- head & neck surgery. 2021 Article GET IT
Times cited: 5
Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers. Cancer. 2021 Academic Article GET IT
Times cited: 42
Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 17
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Nature biotechnology. 2021 Academic Article GET IT
Times cited: 218
3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset. Cancers. 2021 Academic Article GET IT
Times cited: 10
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy. Molecular cancer research : MCR. 2021 Academic Article GET IT
Times cited: 18
HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction?. Cancers. 2021 Academic Article GET IT
Times cited: 31
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence. JCO precision oncology. 2021 Academic Article GET IT
Times cited: 21
Inappropriate Use of the Same Cutoff by Different Sequencing Panels for Tumor Mutation Burden as Immunotherapy Biomarker-Reply. JAMA oncology. 2021 Article GET IT
Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers. The Journal of molecular diagnostics : JMD. 2021 Academic Article GET IT
Times cited: 42
Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer. American journal of cancer research. 2021 Academic Article GET IT
Flexible fiber-based CO₂ laser vs monopolar cautery for resection of oral cavity lesions: A single center randomized controlled trial assessing pain and quality of life following surgery. Laryngoscope investigative otolaryngology. 2021 Academic Article GET IT
Times cited: 5
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. Journal of the National Cancer Institute. 2021 Academic Article GET IT
Times cited: 142
High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab. Molecular cancer research : MCR. 2021 Academic Article GET IT
Times cited: 28
Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase. JAMA oncology. 2021 Academic Article GET IT
Times cited: 178
Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER. Head & neck. 2021 Academic Article GET IT
Times cited: 8
Human Papillomavirus in Patients With Hypopharyngeal Squamous Cell Carcinoma. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2021 Academic Article GET IT
Times cited: 11
Lymph node metastases in pediatric medullary thyroid carcinoma. Surgery. 2021 Academic Article GET IT
Times cited: 7
The role of immune surveillance in malignant transformation of benign salivary gland tumors. Oncotarget. 2021 Academic Article GET IT
Times cited: 4
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Immunity. 2021 Academic Article GET IT
Times cited: 86
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. Journal of the National Cancer Institute. 2021 Academic Article GET IT
Times cited: 60
Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center. International journal of cancer. 2021 Academic Article GET IT
Times cited: 3
OncoTree: A Cancer Classification System for Precision Oncology. JCO clinical cancer informatics. 2021 Academic Article GET IT
Times cited: 114
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors. Nature communications. 2021 Academic Article GET IT
Times cited: 372
The association between tumor mutational burden and prognosis is dependent on treatment context. Nature genetics. 2021 Academic Article GET IT
Times cited: 203
Life Expectancy and Treatment Patterns in Elderly Patients With Low-Risk Papillary Thyroid Cancer: A Population-Based Analysis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2020 Academic Article GET IT
Times cited: 9
Treatment of Early Stage Tonsil Cancer in the Age of Human Papillomavirus-Associated Malignancies. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2020 Academic Article GET IT
Times cited: 4
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. Nature cancer. 2020 Academic Article GET IT
Times cited: 170
The head and neck cancer genome in the era of immunotherapy. Oral oncology. 2020 Information Resource GET IT
Times cited: 16
Association Between Implementation of the 2009 American Thyroid Association Guidelines and De-escalation of Treatment for Low-risk Papillary Thyroid Carcinoma. JAMA otolaryngology-- head & neck surgery. 2020 Academic Article GET IT
Times cited: 12
Nodal disease burden and outcome of medullary thyroid carcinoma. Head & neck. 2020 Academic Article GET IT
Times cited: 17
Association of Study Methods and Industry Sponsorship With Inconsistent Performance of Molecular Assays for Indeterminate Thyroid Nodules. JAMA otolaryngology-- head & neck surgery. 2020 Academic Article GET IT
Times cited: 1
Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status. Journal of surgical oncology. 2020 Academic Article GET IT
Times cited: 10
Molecular Profiling of Thyroid Nodules-Are These Findings Meaningful, or Merely Measurable?: A Review. JAMA otolaryngology-- head & neck surgery. 2020 Information Resource GET IT
Times cited: 17
Augmented reality-enhanced navigation in endoscopic sinus surgery: A prospective, randomized, controlled clinical trial. Laryngoscope investigative otolaryngology. 2020 Academic Article GET IT
Times cited: 36
Host Factors Independently Associated With Prognosis in Patients With Oral Cavity Cancer. JAMA otolaryngology-- head & neck surgery. 2020 Academic Article GET IT
Times cited: 46
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer. Cancer. 2020 Academic Article GET IT
Times cited: 24
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral oncology. 2020 Academic Article GET IT
Times cited: 39
Reversal in Thyroid Cancer Incidence Trends in the United States, 2000-2017. Thyroid : official journal of the American Thyroid Association. 2020 Article GET IT
Times cited: 23
DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden. Cell reports. Medicine. 2020 Academic Article GET IT
Times cited: 67
Assessing the Number of Candidates There Are for Active Surveillance of Low-risk Papillary Thyroid Cancers in the US. JAMA otolaryngology-- head & neck surgery. 2020 Academic Article GET IT
Times cited: 10
Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA otolaryngology-- head & neck surgery. 2020 Information Resource GET IT
Times cited: 461
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma. Cancers. 2020 Academic Article GET IT
Times cited: 52
Racial Disparities in Cancer Presentation and Outcomes: The Contribution of Overdiagnosis. JNCI cancer spectrum. 2020 Academic Article GET IT
Times cited: 12
Characterizing Relative and Disease-Specific Survival in Early-Stage Cancers. JAMA internal medicine. 2020 Academic Article GET IT
Times cited: 20
The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 106
Active surveillance for patients with very low-risk thyroid cancer. Laryngoscope investigative otolaryngology. 2020 Information Resource GET IT
Times cited: 42
Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma. Cancer. 2019 Academic Article GET IT
Times cited: 60
Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016. JAMA. 2019 Academic Article GET IT
Times cited: 81
Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer. Cancer. 2019 Academic Article GET IT
Times cited: 57
Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy. Nature medicine. 2019 Academic Article GET IT
Times cited: 242
The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma. Histopathology. 2019 Academic Article GET IT
Times cited: 48
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma. The Journal of clinical investigation. 2019 Academic Article GET IT
Times cited: 191
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance. Thyroid : official journal of the American Thyroid Association. 2019 Academic Article GET IT
Times cited: 33
Panel-based estimates of tumor mutational burden: characterizing unknown unknowns. Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Editorial Article GET IT
Times cited: 1
APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma. Oral oncology. 2019 Academic Article GET IT
Times cited: 50
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy. Human vaccines & immunotherapeutics. 2019 Academic Article GET IT
Times cited: 63
Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epithelium. Oncotarget. 2019 Academic Article GET IT
Times cited: 9
Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. International journal of cancer. 2019 Academic Article GET IT
Times cited: 49
Lung Cancer Evolution: What's Immunity Got to Do with It?. Cancer cell. 2019 Article GET IT
Times cited: 7
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science (New York, N.Y.). 2019 Academic Article GET IT
Times cited: 456
Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nature medicine. 2019 Article GET IT
Times cited: 323
The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement. Human pathology. 2019 Academic Article GET IT
Times cited: 42
Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. International journal of cancer. 2019 Academic Article GET IT
Times cited: 163
Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature genetics. 2019 Academic Article GET IT
Times cited: 3166
Thyroid Cancer Screening After Nuclear Accidents. JAMA otolaryngology-- head & neck surgery. 2019 Information Resource GET IT
Times cited: 1
American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules. Head & neck. 2018 Information Resource GET IT
Times cited: 14
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway. Cancer cell. 2018 Academic Article GET IT
Times cited: 410
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas. Journal of the National Cancer Institute. 2018 Academic Article GET IT
Times cited: 140
Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. Journal of surgical oncology. 2018 Academic Article GET IT
Times cited: 54
Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer. Surgery. 2018 Academic Article GET IT
Times cited: 52
Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules. Surgery. 2018 Academic Article GET IT
Times cited: 56
Reply to: Selective history of radioactive iodine in medicine: Inexactitudes no longer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018 Article GET IT
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. Cancer cell. 2018 Academic Article GET IT
Times cited: 262
Neck dissection for salivary gland malignancies. Operative techniques in otolaryngology--head and neck surgery. 2018 Academic Article GET IT
Times cited: 14
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science (New York, N.Y.). 2017 Academic Article GET IT
Times cited: 932
Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma. JAMA otolaryngology-- head & neck surgery. 2017 Academic Article GET IT
Times cited: 32
Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma. Journal of surgical oncology. 2017 Academic Article GET IT
Times cited: 40
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques. JAMA oncology. 2017 Academic Article GET IT
Times cited: 209
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions. Nature communications. 2017 Academic Article GET IT
Times cited: 110
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017 Academic Article GET IT
Times cited: 1797
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA otolaryngology-- head & neck surgery. 2017 Academic Article GET IT
Times cited: 411
The thyroid cancer epidemic, 2017 perspective. Current opinion in endocrinology, diabetes, and obesity. 2017 Information Resource GET IT
Times cited: 251
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4⁺ TILs in the Presence of PD-L1⁺ TAMs. Cancer research. 2017 Academic Article GET IT
Times cited: 84
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine. 2017 Article GET IT
Times cited: 52
The USPSTF Recommendation on Thyroid Cancer Screening: Don't "Check Your Neck". JAMA otolaryngology-- head & neck surgery. 2017 Editorial Article GET IT
Times cited: 14
Increases in Thyroid Cancer Incidence and Mortality. JAMA. 2017 Article GET IT
Times cited: 30
Reply to: Radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Article GET IT
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 106
Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database. Journal of surgical oncology. 2017 Academic Article GET IT
Times cited: 7
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine. 2017 Academic Article GET IT
Times cited: 2765
Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all". European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Information Resource GET IT
Times cited: 34
Androgen Receptor Signaling in Salivary Gland Cancer. Cancers. 2017 Information Resource GET IT
Times cited: 82
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM. Oncotarget. 2017 Article GET IT
Times cited: 36
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform. JAMA oncology. 2017 Academic Article GET IT
Times cited: 212
The head and neck cancer immune landscape and its immunotherapeutic implications. JCI insight. 2016 Academic Article GET IT
Times cited: 651
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Academic Article GET IT
Times cited: 109
Ethical Considerations When Counseling Patients With Thyroid Cancer About Surgery vs Observation. JAMA otolaryngology-- head & neck surgery. 2016 Article GET IT
Times cited: 11
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors. Science signaling. 2016 Academic Article GET IT
Times cited: 58
Robotics in otolaryngology and head and neck surgery: Recommendations for training and credentialing: A report of the 2015 AHNS education committee, AAO-HNS robotic task force and AAO-HNS sleep disorders committee. Head & neck. 2016 Information Resource GET IT
Times cited: 43
Impact of elective neck dissection on the outcome of oral squamous cell carcinomas arising in the maxillary alveolus and hard palate. Head & neck. 2015 Academic Article GET IT
Times cited: 29
Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. The British journal of surgery. 2015 Academic Article GET IT
Times cited: 77
Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma. Head & neck. 2015 Academic Article GET IT
Times cited: 18
Prognostic factors in myoepithelial carcinoma of salivary glands: a clinicopathologic study of 48 cases. The American journal of surgical pathology. 2015 Academic Article GET IT
Times cited: 72
Resistance to EGFR inhibitors: molecular determinants and the enigma of head and neck cancer. Oncotarget. 2011 Editorial Article GET IT
Times cited: 10
Eyelash trichomegaly secondary to panitumumab therapy. Current oncology (Toronto, Ont.). 2011 Academic Article GET IT
Times cited: 14
Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot study. The Journal of laryngology and otology. 2010 Academic Article GET IT
Times cited: 46
Blood clot cast of the tracheobronchial tree. ANZ journal of surgery. 2010 Article GET IT
Times cited: 4
Retraction. When is surgery indicated for asymptomatic primary hyperparathyroidism?. The Laryngoscope. 2009 Article GET IT
Chondromyxoid fibroma of sphenoid sinus with unusual calcifications: case report with literature review. Head and neck pathology. 2009 Article GET IT
Times cited: 18
Endoscopic endonasal surgery for petrous apex lesions. The Laryngoscope. 2009 Academic Article GET IT
Times cited: 204
REM-associated nasal obstruction: a study with acoustic rhinometry during sleep. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2008 Academic Article GET IT
Times cited: 11
Intractable hiccoughs in pregnancy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2004 Article GET IT
Times cited: 3
Primary sphenoid sinus esthesioneuroblastoma. American journal of otolaryngology. 2004 Article GET IT
Times cited: 32

more ...

less ...

Background

education and training

M.Sc., Columbia University 2011
M.D., New York University School of Medicine 2004
Sc.B., Brown University 2000

Contact

full name

Luc Morris

VIVO Weill Cornell Medical College

Luc Morris Professor of Otolaryngology

Publications

selected publications

Background

education and training

Contact

full name